Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in Children With MDR-TB With and Without HIV
Clinical trial NCT03141060 · COMPLETED
Trial details
- NCT number
- NCT03141060
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-18
- Primary completion
- 2025-04-22
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.